Literature DB >> 31374332

Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study.

Flora Devos1, Frantz Foissac2, Naim Bouazza2, Pierre-Yves Ancel3, Jean-Marc Tréluyer4, Hélène Chappuy5.   

Abstract

OBJECTIVES: The objective of this study was to examine the impact of study characteristics on the score of the pragmatism/explanatory continuum of randomized controlled trials (RCTs) published in nursing journals using the PRagmatic Explanatory Continuum Indicator Summary (PRECIS)-2 tool. STUDY DESIGN AND
SETTING: RCTs concerning five themes of nursing care indexed in the PubMed and CINAHL databases published from 2002 to 2005 and 2012 to 2015 were selected by title/abstract. A sample of 400 was randomly selected and evaluated with the PRECIS-2 tool and reading grid.
RESULTS: The median PRECIS score was 32 of a possible 45 [28; 36] corresponding to a medium level of pragmatism. Studies with "medication" as an intervention had a more explanatory PRECIS score than studies with other intervention types (P = 0.015). Studies with "placebo" and "no usual care" as comparators had a more explanatory PRECIS score (P = 0.0027). The pragmatism/explanatory level was unaffected by impact factor (P = 0.42), h-index of the first and last author (P = 0.27 and P = 0.25, respectively), funding (P = 0.32), blinding (P = 0.41), sample size (P = 0.22), and time (P = 0.11).
CONCLUSION: This study highlights the pragmatism/explanatory level of nursing RCTs, the impact of the field of the article, and the comparator type on the pragmatism of these studies. Further studies are needed to confirm the astonishing result that blinding resulted in no significant difference in the PRECIS score.
Copyright © 2019 Elsevier Inc. All rights reserved.

Keywords:  Applicability; Knowledge transfer; Methodology; Nursing; PRECIS-2 tool; Pragmatism; Randomized controlled trials

Mesh:

Year:  2019        PMID: 31374332     DOI: 10.1016/j.jclinepi.2019.07.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2020-10-26       Impact factor: 2.953

Review 2.  A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

Authors:  Stuart G Nicholls; Kelly Carroll; Spencer Phillips Hey; Merrick Zwarenstein; Jennifer Zhe Zhang; Hayden P Nix; Jamie C Brehaut; Joanne E McKenzie; Steve McDonald; Charles Weijer; Dean A Fergusson; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2021-03-28       Impact factor: 6.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.